

[ Mon, Feb 08th 2021
] - WOPRAI
[ Mon, Feb 08th 2021
] - WOPRAI
[ Mon, Feb 08th 2021
] - WOPRAI
[ Mon, Feb 08th 2021
] - WOPRAI
[ Mon, Feb 08th 2021
] - WOPRAI
[ Mon, Feb 08th 2021
] - WOPRAI
[ Mon, Feb 08th 2021
] - WOPRAI
[ Mon, Feb 08th 2021
] - WOPRAI
[ Mon, Feb 08th 2021
] - WOPRAI
[ Mon, Feb 08th 2021
] - WOPRAI
[ Mon, Feb 08th 2021
] - WOPRAI
[ Mon, Feb 08th 2021
] - WOPRAI
[ Mon, Feb 08th 2021
] - WOPRAI
[ Mon, Feb 08th 2021
] - WOPRAI
[ Mon, Feb 08th 2021
] - WOPRAI
[ Mon, Feb 08th 2021
] - WOPRAI
[ Mon, Feb 08th 2021
] - WOPRAI
[ Mon, Feb 08th 2021
] - WOPRAI
[ Mon, Feb 08th 2021
] - WOPRAI
[ Mon, Feb 08th 2021
] - WOPRAI
[ Mon, Feb 08th 2021
] - WOPRAI
[ Mon, Feb 08th 2021
] - WOPRAI
[ Mon, Feb 08th 2021
] - WOPRAI
[ Mon, Feb 08th 2021
] - WOPRAI
[ Mon, Feb 08th 2021
] - WOPRAI
[ Mon, Feb 08th 2021
] - WOPRAI
[ Mon, Feb 08th 2021
] - WOPRAI
Puneet Souda Maintained (ABCL) at Buy with Increased Target to $52 on, Feb 8th, 2021
Puneet Souda of SVB Leerink, Maintained "AbCellera Biologics Inc." (ABCL) at Buy with Increased Target from $45 to $52 on, Feb 8th, 2021.
Puneet has made no other calls on ABCL in the last 4 months.
There are 4 other peers that have a rating on ABCL. Out of the 4 peers that are also analyzing ABCL, 0 agree with Puneet's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Puneet
- Do Kim of "BMO Capital" Initiated at Buy and Held Target at $48 on, Tuesday, January 5th, 2021
- Gal Munda of "Berenberg" Initiated at Strong Buy and Held Target at $53 on, Tuesday, January 5th, 2021
- Stephen Willey of "Stifel" Initiated at Strong Buy and Held Target at $59 on, Tuesday, January 5th, 2021
- Tiago Fauth of "Credit Suisse" Initiated at Buy on, Tuesday, January 5th, 2021
Contributing Sources